Skip to main content
. 2021 Aug 17;8:663646. doi: 10.3389/fmed.2021.663646

Table 1.

Clinical characteristics of patients with COVID-19.

Variable Patients of COVID-19 with pancreatitis Patients of COVID-19 with elevated
pancreatic enzymes
(N = 29)
Patients of COVID-19 without
elevated enzymes
(N = 23)
P
P1 P2 P3 Overall
Age (mean) 55 45 29 43 ± 13 63 ± 12 61 ± 11 0.18
Sex, male n (%) N Y N 2(66.7) 18(62.1) 17(73.9) 0.72
Epidemiology N N N 0(0) 0(0) 0(0)
Comorbidities, n(%)
Hypertension N N N 0(0) 13(44.8) 9(39.1) 0.41
Diabetes N N N 0(0) 6(20.7) 4(17.4) 1
COPD N N N 0(0) 0(0) 0(0)
Cardiac disease Y N N 1(33.3) 2(6.9) 2(8.7) 0.37
Chronic Renal disease N N N 0(0) 1(3.4) 2(8.7) 0.64
Carcinoma N N N 0(0) 1(3.4) 3(13) 0.46
HCV N N N 0(0) 0(0) 0(0)
HIV N N N 0(0) 0(0) 0(0)
Hyperlipidemia Y N N 1(33.3) 0(0) 0(0) 0.05

COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; HCV, hepatitis C virus. The enrolled patients were aged between 29 and 79 years. Eighteen (32.7%) were women, the median age was 63 years and the average age was 61 years.